FDA Approves Unknown Drug — MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has received FDA approval for ANDA214216 dated April 7, 2026, signaling a strategic foothold within the pharmaceutical market, subject to planned comme…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Macleods Pharmaceuticals Ltd has received FDA approval for ANDA214216 dated April 7, 2026, signaling a strategic foothold within the pharmaceutical market, subject to planned comme…
# FDA Approves Generic Dapagliflozin from Ajanta Pharma USA The U.S. FDA has approved Ajanta Pharma USA Inc.'s generic version of dapagliflozin, an SGLT2 inhibitor used to treat t…
# FDA Approves CIPLA Generic Drug Application Cipla Limited has received FDA approval for its abbreviated new drug application (ANDA 211595), expanding the company's generic pharm…
# FDA Approves Generic Dapagliflozin; Teva Pharmaceuticals Enters Competitive SGLT2 Inhibitor Market Teva Pharmaceuticals, Inc. received FDA approval for its generic dapagliflozin…
# FDA Approves Teva Pharmaceuticals Generic Drug Application Teva Pharmaceuticals USA Inc. received FDA approval for ANDA 211583 on April 6, 2026, potentially expanding its generi…
# FDA Approves Generic Version of DAPAGLIFLOZIN The U.S. Food and Drug Administration has approved Zydus Lifesciences Limited's generic formulation of dapagliflozin (ANDA211582), …
# FDA Approves ANDA for Micro Labs Micro Labs has received FDA approval for an abbreviated new drug application (ANDA211466), expanding its generic drug portfolio and positioning …
# FDA Approves Generic Dapagliflozin from Florida Pharmaceutical Products The FDA has approved Florida Pharmaceutical Products, LLC's generic formulation of dapagliflozin (ANDA211…
# FDA Approves Generic Dapagliflozin from Macleods Pharmaceuticals The U.S. FDA has approved Macleods Pharmaceuticals Limited's generic version of dapagliflozin, an SGLT2 inhibito…
# FDA Approves Generic Drug Application for Cipla Ltd Cipla Ltd received FDA approval for an abbreviated new drug application (ANDA211536) on April 6, 2026, expanding the company'…
# FDA Approves Generic Version of Dapagliflozin and Saxagliptin Combination Novadoz Pharmaceuticals LLC has received FDA approval for a generic formulation of dapagliflozin and sa…
# FDA Approves Torrent's ANDA Application Torrent Pharmaceuticals has received FDA approval for its abbreviated new drug application (ANDA211537), expanding the company's generic …
# FDA Approves AvKARE's Generic Dapagliflozin AvKARE has received FDA approval for its generic dapagliflozin oral formulation, marking another entry into the competitive SGLT2 inh…
# FDA Approves Generic DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE Combination Macleods Pharmaceuticals Limited received FDA approval for its generic dapagliflozin and metformin hyd…
# FDA Approves Generic Dapagliflozin from Alembic Pharmaceuticals The U.S. FDA has approved Alembic Pharmaceuticals Limited's generic dapagliflozin oral formulation, expanding com…
Sun Pharmaceutical Industries, Inc. secured FDA approval for its oral generic Dapagliflozin and Metformin Hydrochloride tablets, positioning the company to expand its competitive p…
Cipla USA Inc. secured FDA approval for its generic oral tablet of Dapagliflozin, positioning the manufacturer to capture market share in the growing diabetes treatment sector. Thi…
Biocon Pharma Inc. secured FDA approval for its generic oral formulation of Dapagliflozin via ANDA211470, with the product slated for a market entry in April 2026. This regulatory …
Ascend Laboratories received FDA approval for its Generic Dapagliflozin and Metformin Hydrochloride tablets, a critical oral combination therapy for type 2 diabetes. This launch is…
The FDA has granted full approval to generic dapagliflozin manufactured by Apotex Corp., paving the way for the company to capture market share in the widely prescribed SGLT2 inhib…